About
A global fund with over $1.3B AUM, with offices in Israel and Boston, USA. aMoon leverages pioneering scientific research, raw talent, and the convergence of health and technology. As Israel’s largest HealthTech-only VC fund, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare and help people live better, healthier lives.
aMoon invests across all stages of a company’s lifecycle through three investment vehicles: aMoon Velocity, our early-stage fund, aMoon Growth, our mid-late-stage fund, and aMoon Edge, our public equities fund.
We leverage our multidisciplinary team of scientists, physicians, and entrepreneurs, along with our robust network of investors and industry leaders, to build bridges between our portfolio companies and global HealthTech hubs, supporting entrepreneurs from the inception of an idea to company launch.
Portfolio
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is aMoon Fund's primary investment focus?
- aMoon Fund is Israel's largest HealthTech-only VC fund, focusing on companies that leverage groundbreaking science and technology to transform healthcare.
- What is the total AUM for aMoon Fund?
- aMoon Fund has over $1.3 billion in Assets Under Management (AUM).
- Which investment vehicles does aMoon Fund utilize?
- aMoon Fund invests across all stages through three vehicles: aMoon Velocity (early-stage), aMoon Growth (mid-late-stage), and aMoon Edge (public equities).
- Can you name a notable exit for aMoon Fund?
- A notable exit for aMoon Fund was Zebra Medical Vision, which was acquired by Nanox Vision for $200 million in August 2021. Another is MetaSight Diagnostics, acquired by Guardant Health for $150 million in February 2026.
- What was a significant fundraising event for aMoon Fund in recent years?
- aMoon Fund raised $340 million for its second fund in July 2022, following a $750 million close for a healthtech fund in July 2020.
- Has aMoon Fund led any significant investment rounds recently?
- In August 2025, aMoon Fund led a $51.5 million round for Positive Development. In July 2025, aMoon Fund led an investment in Magentiq Eye to drive AI-powered gastroenterology.
- What is aMoon Fund's geographic presence?
- aMoon Fund has offices in Ra'anana, Israel, and Boston, USA.
- When was aMoon Fund founded?
- aMoon Fund was founded in 2017.
- Which company did aMoon Fund see a significant return on investment from?
- aMoon Fund saw a 15-fold return on its investment in Seer, with its stake valued at $470 million in February 2021.